Clinical pathology for clinical trials 

Clinical pathology for clinical trials has become an indispensable tool for the implementation and acceleration of new therapies and also contributes to the production of fundamental knowledge in medicine and human biology.



oncology trials since 2018



essais cliniques en maladies infectieuses depuis 2018



essais cliniques en thérapie cellulaire & génique depuis 2018 (50% en Phase 1)

Serving the biotechnology, pharmaceutical and in vitro diagnostics industries.

We combine the deep expertise and agility of the specialist laboratory with the capacity, breadth and global reach of a central lab, providing the best of both worlds.
Our unique approach to patient data offers our customers the opportunity to have one partner for all their test services, with regular access and consistent support across all clinical trial phases.

Cerba Research, a combined offer :

A Global Central Lab

committed to providing the most innovative scientific solutions in a personalized manner.

A global Specialty lab

with access to state of the art technologies for trials.

A unique approach to patient data

that offers our customers the opportunity to have one partner for all their test services.

Our comprehensive lab infrastructure, global footprint and proven processes mean that today we: 

Have access to biomedical and genetic data from over 50 million patients per year from across Europe, Africa and North America.


Offer unique access to Africa’s growing population including diverse samples for non-clinical research.

Have the ability to sequence 1000-plus whole human genomes per week. 



Provide a gateway for customers to conduct studies in China and offer broad local capabilities within an integrated global solution.

Our expertise for tomorrow’s health

Card_Biologie_De_Proximite_327x425 (1).png

Routine clinical pathology


Specialised clinical pathology


Clinical pathology for clinical trials



Cards_325x4255_0 (1).jpg

Medical imaging


Preventive testing